Immunome Inc (IMNM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 49,229 | 56,243 | 59,829 | 36,276 | 39,766 |
| TOTAL | $56,638 | $61,190 | $62,815 | $41,107 | $42,894 |
| Non-Current Assets | |||||
| PPE Net | 855 | 961 | 1,226 | 1,386 | 1,531 |
| Other Non-Current Assets | 432 | 407 | 100 | 100 | 100 |
| TOTAL | $1,287 | $1,368 | $1,326 | $1,486 | $1,631 |
| Total Assets | $57,925 | $62,558 | $64,141 | $42,593 | $44,525 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | N/A | 366 | 366 |
| Accounts payable and accrued liabilities | 3,077 | 3,277 | 1,790 | 2,958 | 1,187 |
| Accrued Expenses | 6,651 | 4,472 | 1,687 | 1,169 | 1,372 |
| TOTAL | $9,728 | $7,765 | $3,521 | $4,571 | $3,038 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | N/A | N/A | 134 | 134 |
| Other Non-Current Liabilities | 12 | 0 | 0 | 0 | 0 |
| TOTAL | $12 | $N/A | $3 | $139 | $142 |
| Total Liabilities | $9,740 | $7,765 | $3,524 | $4,710 | $3,180 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 12,127 | 12,100 | 11,814 | 11,757 | 10,660 |
| Common Shares | 1 | 1 | 1 | 1 | 1 |
| Retained earnings | -79,105 | -71,253 | -63,533 | -58,292 | -54,394 |
| TOTAL | $48,185 | $54,793 | $60,617 | $37,883 | $41,345 |
| Total Liabilities And Equity | $57,925 | $62,558 | $64,141 | $42,593 | $44,525 |